BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30338738)

  • 1. HSF1 as a Cancer Biomarker and Therapeutic Target.
    Carpenter RL; Gökmen-Polar Y
    Curr Cancer Drug Targets; 2019; 19(7):515-524. PubMed ID: 30338738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting Heat Shock Factor 1 in Cancer: A Unique Therapeutic Opportunity.
    Dong B; Jaeger AM; Thiele DJ
    Trends Pharmacol Sci; 2019 Dec; 40(12):986-1005. PubMed ID: 31727393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Inhibitors of HSF1-Activated Pathways as Potential Next-Generation Anticancer Therapeutics.
    Sharma C; Seo YH
    Molecules; 2018 Oct; 23(11):. PubMed ID: 30356024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock factor 1 (HSF1)-targeted anticancer therapeutics: overview of current preclinical progress.
    Kijima T; Prince T; Neckers L; Koga F; Fujii Y
    Expert Opin Ther Targets; 2019 May; 23(5):369-377. PubMed ID: 30931649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of HSF1 in cancer: Cellular and molecular episodes.
    Wang G; Cao P; Fan Y; Tan K
    Biochim Biophys Acta Rev Cancer; 2020 Aug; 1874(1):188390. PubMed ID: 32653364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of HSF1 Protein in Malignant Transformation.
    Šimončík O; Pastorek M; Vojtěšek B; Müller P
    Klin Onkol; 2018; 31(Suppl 2):55-62. PubMed ID: 31023025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of HSF1 by PIM2 Induces PD-L1 Expression and Promotes Tumor Growth in Breast Cancer.
    Yang T; Ren C; Lu C; Qiao P; Han X; Wang L; Wang D; Lv S; Sun Y; Yu Z
    Cancer Res; 2019 Oct; 79(20):5233-5244. PubMed ID: 31409638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target.
    Fok JHL; Hedayat S; Zhang L; Aronson LI; Mirabella F; Pawlyn C; Bright MD; Wardell CP; Keats JJ; De Billy E; Rye CS; Chessum NEA; Jones K; Morgan GJ; Eccles SA; Workman P; Davies FE
    Clin Cancer Res; 2018 May; 24(10):2395-2407. PubMed ID: 29391353
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting HSF1 for cancer treatment: mechanisms and inhibitor development.
    Chin Y; Gumilar KE; Li XG; Tjokroprawiro BA; Lu CH; Lu J; Zhou M; Sobol RW; Tan M
    Theranostics; 2023; 13(7):2281-2300. PubMed ID: 37153737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Multifaceted Role of HSF1 in Tumorigenesis.
    Alasady MJ; Mendillo ML
    Adv Exp Med Biol; 2020; 1243():69-85. PubMed ID: 32297212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic role of HSF1 in neoplastic transformation.
    Vydra N; Toma A; Widlak W
    Curr Cancer Drug Targets; 2014; 14(2):144-55. PubMed ID: 24467529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HSF1: Primary Factor in Molecular Chaperone Expression and a Major Contributor to Cancer Morbidity.
    Prince TL; Lang BJ; Guerrero-Gimenez ME; Fernandez-Muñoz JM; Ackerman A; Calderwood SK
    Cells; 2020 Apr; 9(4):. PubMed ID: 32331382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AMPK activation promotes the invasion and metastasis of pancreatic cancer through an HSF1-dependent pathway.
    Chen K; Qian W; Li J; Jiang Z; Cheng L; Yan B; Cao J; Sun L; Zhou C; Lei M; Duan W; Ma J; Ma Q; Ma Z
    Mol Oncol; 2017 Oct; 11(10):1475-1492. PubMed ID: 28783244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock factor 1 inhibits the mitochondrial apoptosis pathway by regulating second mitochondria-derived activator of caspase to promote pancreatic tumorigenesis.
    Liang W; Liao Y; Zhang J; Huang Q; Luo W; Yu J; Gong J; Zhou Y; Li X; Tang B; He S; Yang J
    J Exp Clin Cancer Res; 2017 May; 36(1):64. PubMed ID: 28482903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat Shock Factor 1 Predicts Poor Prognosis of Gastric Cancer.
    Kim SJ; Lee SC; Kang HG; Gim J; Lee KH; Lee SH; Chun KH
    Yonsei Med J; 2018 Nov; 59(9):1041-1048. PubMed ID: 30328318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The heat-shock, or HSF1-mediated proteotoxic stress, response in cancer: from proteomic stability to oncogenesis.
    Dai C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jan; 373(1738):. PubMed ID: 29203710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpressed HSF1 cancer signature genes cluster in human chromosome 8q.
    Zhang CQ; Williams H; Prince TL; Ho ES
    Hum Genomics; 2017 Dec; 11(1):35. PubMed ID: 29268782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of heat shock factor 1 (HSF1) is associated with poor survival in gastric cancer patients.
    Dai W; Ye J; Zhang Z; Yang L; Ren H; Wu H; Chen J; Ma J; Zhai E; Cai S; He Y
    Diagn Pathol; 2018 Oct; 13(1):80. PubMed ID: 30326922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic proteotoxic stress levels vary and act as a predictive marker for sensitivity of cancer cells to Hsp90 inhibition.
    Pastorek M; Muller P; Coates PJ; Vojtesek B
    PLoS One; 2018; 13(8):e0202758. PubMed ID: 30138434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rethinking HSF1 in Stress, Development, and Organismal Health.
    Li J; Labbadia J; Morimoto RI
    Trends Cell Biol; 2017 Dec; 27(12):895-905. PubMed ID: 28890254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.